home / stock / crl / crl news


CRL News and Press, Charles River Laboratories International Inc.

Stock Information

Company Name: Charles River Laboratories International Inc.
Stock Symbol: CRL
Market: NYSE
Website: criver.com

Menu

Get CRL Alerts

News, Short Squeeze, Breakout and More Instantly...

CRL - US Companies Moving the Markets, Morning edition
Fri, Jul 10, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Zhibao Technology Inc. (ZBAO) rose 47.4% to $0.43625 on volume of 191,062,211 shares T3 Defense Inc. (DFNS) fell 19.7% to $0.118 on volume of 140,059,194 shares Direxion Daily Semiconductor Bear 3X (SOXS) rose 4.0% to $4.2314 on volume ...

CRL - Citi's picks and pans for H2 '26: REITs, tech, consumer, health

2026-07-05 14:37:17 ET More on SPDR S&P 500 ETF Trust A $350 Billion Liquidity Drain Is Set To Hit Markets This Summer The Millionaire Boom Is Real - But So Is The Market Trap This Bull Market Should Charge Into 2027 Citi picks and pans for H2 '26: fintec...

CRL - Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis...

CRL - CRL Price Target Alert: $250.00. Issued by Bernstein

2026-07-01 06:15:03 ET from Bernstein issued a price target of $250.00 for CRL on 2026-07-01 07:56:00. The adjusted price target was set to $250.00. At the time of the announcement, CRL was trading at $226.79. The overall price target consensus is at $214.14 with high pr...

CRL - Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus

2026-06-28 09:05:16 ET More on State Street Health Care Select Sector SPDR ETF AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit Merck's Bio-Techne buyout put Life Sciences sector in focus: ...

CRL - Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?

2026-06-22 18:04:44 ET Is your portfolio better served by a diagnostic equipment leader or a pharmaceutical research titan? Deciding between Bio-Rad Laboratories (NYSE:BIO) and Charles River Laboratories International (NYSE:CRL) requires weighing specialized equipment agains...

CRL - Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab , a collaborative...

CRL - Charles River upgraded, IQVIA downgraded as Morgan Stanley revisits CRO coverage

2026-06-17 10:14:23 ET More on Charles River Laboratories, IQVIA Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcri...

CRL - Citrini sees new upside in healthcare stocks, updates basket

2026-06-09 11:41:44 ET More on Health Care stocks AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech Weekly ETFs: Six...

CRL - Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus

2026-06-07 09:05:07 ET More on State Street Health Care Select Sector SPDR ETF AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit Routine Vaccines Okay For Now: Investment Implications Of The...

Next 10